Abstract

A vast portion of the mammalian genome is transcribed as long non-coding RNAs (lncRNAs) acting in the cytoplasm with largely unknown functions. Surprisingly, lncRNAs have been shown to interact with ribosomes, encode peptides, or act as ribosome sponges. These functions still remain mostly undetected and understudied owing to the lack of efficient tools for genome-wide simultaneous identification of ribosome-associated and peptide-producing lncRNAs. Here we present AHARIBO, a method for the detection of lncRNAs either untranslated, but associated with ribosomes, or encoding small peptides. Using AHARIBO in mouse embryonic stem cells during neuronal differentiation, we isolated ribosome-protected RNA fragments, translated RNAs and corresponding de novo synthesized peptides. Besides identifying mRNAs under active translation and associated ribosomes, we found and distinguished lncRNAs acting as ribosome sponges or encoding micropeptides, laying the ground for a better functional understanding of hundreds lncRNAs.

Data availability

All data generated or analysed during this study are included in the manuscript and supporting files. Source data files have been provided. All sequencing data are deposited in public archives and made available upon publication.

The following previously published data sets were used

Article and author information

Author details

  1. Luca Minati

    Ribosome engineering, IMMAGINA biotechnology, Trento, Italy
    Competing interests
    Luca Minati, L.M is an employee of IMMAGINA BioTechnology S.r.l..
  2. Claudia Firrito

    Ribosome engineering, IMMAGINA biotechnology, Trento, Italy
    Competing interests
    Claudia Firrito, C.F. is an employee of IMMAGINA BioTechnology S.r.l..
  3. Alessia Del Piano

    Ribosome engeneering, IMMAGINA biotechnology, Trento, Italy
    Competing interests
    Alessia Del Piano, A.D.P is an employee of IMMAGINA BioTechnology S.r.l..
  4. Alberto Peretti

    Ribosome engineering, IMMAGINA biotechnology, Trento, Italy
    Competing interests
    Alberto Peretti, A.P. is an employee of IMMAGINA BioTechnology S.r.l..
  5. Simone Sidoli

    Department of Biochemistry, Albert Einstein College of Medicine, Bronx, United States
    Competing interests
    No competing interests declared.
  6. Daniele Peroni

    Mass Spectrometry Facility, Computational and Integrative Biology (CIBIO), University of Trento, Trento, Italy
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-0862-266X
  7. Romina Belli

    Mass Spectrometry Facility, Computational and Integrative Biology (CIBIO), University of Trento, Trento, Italy
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-5690-2797
  8. Francesco Gandolfi

    Laboratory of Bioinformatics and Computational Genomics, Computational and Integrative Biology (CIBIO), University of Trento, Trento, Italy
    Competing interests
    No competing interests declared.
  9. Alessandro Romanel

    Laboratory of Bioinformatics and Computational Genomics, Department of Cellular, Computational and Integrative Biology (CIBIO), University of Trento, Trento, Italy
    Competing interests
    No competing interests declared.
  10. Paola Bernabo

    Ribosome engineering, IMMAGINA biotechnology, Trento, Italy
    Competing interests
    Paola Bernabo, P.B is an employee of IMMAGINA BioTechnology S.r.l..
  11. Jacopo Zasso

    Department of Cellular, Computational and Integrative Biology (CIBIO), University of Trento, Trento, Italy
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-3151-6443
  12. Alessandro Quattrone

    Department of Cellular, Computational and Integrative Biology (CIBIO), University of Trento, Trento, Italy
    Competing interests
    Alessandro Quattrone, A.Q is a shareholder of IMMAGINA BioTechnology S.r.l.
  13. Graziano Guella

    Department of Physics, University of Trento, Trento, Italy
    Competing interests
    Graziano Guella, G.G. is shareholders of IMMAGINA BioTechnology S.r.l.
  14. Fabio Lauria

    Institute of Biophysics, CNR Unit at Trento, Trento, Italy
    Competing interests
    No competing interests declared.
  15. Gabriella Viero

    Institute of Biophysics, CNR Unit at Trento, Trento, Italy
    Competing interests
    Gabriella Viero, G.V is a scientific advisor of IMMAGINA BioTechnology S.r.l..
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-6755-285X
  16. Massimiliano Clamer

    Ribosome engineering, IMMAGINA biotechnology, Trento, Italy
    For correspondence
    mclamer@immaginabiotech.com
    Competing interests
    Massimiliano Clamer, M.C. is the founder of, director of, and a shareholder in IMMAGINA BioTechnology S.r.l., a company engaged in the development of new technologies for gene expression analysis at the ribosomal level..
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-8185-059X

Funding

Autonumus Province of Trento adn Banca Intesa (LP6/99)

  • Luca Minati
  • Claudia Firrito
  • Alessia Del Piano
  • Alberto Peretti
  • Paola Bernabo
  • Massimiliano Clamer

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Copyright

© 2021, Minati et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 3,153
    views
  • 502
    downloads
  • 17
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Luca Minati
  2. Claudia Firrito
  3. Alessia Del Piano
  4. Alberto Peretti
  5. Simone Sidoli
  6. Daniele Peroni
  7. Romina Belli
  8. Francesco Gandolfi
  9. Alessandro Romanel
  10. Paola Bernabo
  11. Jacopo Zasso
  12. Alessandro Quattrone
  13. Graziano Guella
  14. Fabio Lauria
  15. Gabriella Viero
  16. Massimiliano Clamer
(2021)
One-shot analysis of translated mammalian lncRNAs with AHARIBO
eLife 10:e59303.
https://doi.org/10.7554/eLife.59303

Share this article

https://doi.org/10.7554/eLife.59303

Further reading

    1. Cell Biology
    2. Developmental Biology
    Pavan K Nayak, Arul Subramanian, Thomas F Schilling
    Research Article Updated

    Mechanical forces play a critical role in tendon development and function, influencing cell behavior through mechanotransduction signaling pathways and subsequent extracellular matrix (ECM) remodeling. Here, we investigate the molecular mechanisms by which tenocytes in developing zebrafish embryos respond to muscle contraction forces during the onset of swimming and cranial muscle activity. Using genome-wide bulk RNA sequencing of FAC-sorted tenocytes we identify novel tenocyte markers and genes involved in tendon mechanotransduction. Embryonic tendons show dramatic changes in expression of matrix remodeling associated 5b (mxra5b), matrilin 1 (matn1), and the transcription factor kruppel-like factor 2a (klf2a), as muscles start to contract. Using embryos paralyzed either by loss of muscle contractility or neuromuscular stimulation we confirm that muscle contractile forces influence the spatial and temporal expression patterns of all three genes. Quantification of these gene expression changes across tenocytes at multiple tendon entheses and myotendinous junctions reveals that their responses depend on force intensity, duration, and tissue stiffness. These force-dependent feedback mechanisms in tendons, particularly in the ECM, have important implications for improved treatments of tendon injuries and atrophy.

    1. Cancer Biology
    2. Cell Biology
    Ida Marie Boisen, Nadia Krarup Knudsen ... Martin Blomberg Jensen
    Research Article

    Testicular microcalcifications consist of hydroxyapatite and have been associated with an increased risk of testicular germ cell tumors (TGCTs) but are also found in benign cases such as loss-of-function variants in the phosphate transporter SLC34A2. Here, we show that fibroblast growth factor 23 (FGF23), a regulator of phosphate homeostasis, is expressed in testicular germ cell neoplasia in situ (GCNIS), embryonal carcinoma (EC), and human embryonic stem cells. FGF23 is not glycosylated in TGCTs and therefore cleaved into a C-terminal fragment which competitively antagonizes full-length FGF23. Here, Fgf23 knockout mice presented with marked calcifications in the epididymis, spermatogenic arrest, and focally germ cells expressing the osteoblast marker Osteocalcin (gene name: Bglap, protein name). Moreover, the frequent testicular microcalcifications in mice with no functional androgen receptor and lack of circulating gonadotropins are associated with lower Slc34a2 and higher Bglap/Slc34a1 (protein name: NPT2a) expression compared with wild-type mice. In accordance, human testicular specimens with microcalcifications also have lower SLC34A2 and a subpopulation of germ cells express phosphate transporter NPT2a, Osteocalcin, and RUNX2 highlighting aberrant local phosphate handling and expression of bone-specific proteins. Mineral disturbance in vitro using calcium or phosphate treatment induced deposition of calcium phosphate in a spermatogonial cell line and this effect was fully rescued by the mineralization inhibitor pyrophosphate. In conclusion, testicular microcalcifications arise secondary to local alterations in mineral homeostasis, which in combination with impaired Sertoli cell function and reduced levels of mineralization inhibitors due to high alkaline phosphatase activity in GCNIS and TGCTs facilitate osteogenic-like differentiation of testicular cells and deposition of hydroxyapatite.